Target Price | $17.70 |
Price | $5.51 |
Potential |
221.23%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Inovio Pharmaceuticals, Inc. 2025 .
The average Inovio Pharmaceuticals, Inc. target price is $17.70.
This is
221.23%
register free of charge
$33.00
498.91%
register free of charge
$8.00
45.19%
register free of charge
|
|
A rating was issued by 6 analysts: 3 Analysts recommend Inovio Pharmaceuticals, Inc. to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Inovio Pharmaceuticals, Inc. stock has an average upside potential 2025 of
221.23%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.83 | 0.33 |
91.91% | 59.73% | |
Net Margin | -19,047.76% | -38,609.80% |
435.05% | 102.70% |
6 Analysts have issued a sales forecast Inovio Pharmaceuticals, Inc. 2024 . The average Inovio Pharmaceuticals, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued a net profit forecast Inovio Pharmaceuticals, Inc. 2024 . The average Inovio Pharmaceuticals, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -6.09 | -4.97 |
56.72% | 18.39% | |
P/E | negative | |
EV/Sales | 136.52 |
1 Analysts have issued a Inovio Pharmaceuticals, Inc. forecast for earnings per share. The average Inovio Pharmaceuticals, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Inovio Pharmaceuticals, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Inovio Pharmaceuticals, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.